FIELD: medicine.
SUBSTANCE: to determine a risk of cell malignancy, a biopsy material taken from an individual is used to prepare a cell smear or a cell suspension in the hypoxic environment. The material is exposed to a pathogenic agent specified in UV light. The recurrent UV light exposure is followed by spectrofluorometry of the sample, and if the dark environment is characterised by an increase of NAD(P)H fluorescence intensity, the cells are diagnosed as malignant.
EFFECT: invention provides detecting the high-resistant cancer cells as negative cancer prediction measures in vivo for the cancer that are used to take the sample; a time of malignancy detection and cancer cell resistance makes a few minutes.
6 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSING CANCER AND POTENTIAL RESISTANCE OF MALIGNANT CELLS TO HYPOXIA | 2011 |
|
RU2463963C1 |
| MEANS FOR TREATMENT OF MALIGNANT ASCITIC TUMOURS | 2011 |
|
RU2464974C1 |
| METAL-GLYCOPROTEIN COMPLEXES AND USE THEREOF AS CHEMOTHERAPEUTIC COMPOUNDS | 2016 |
|
RU2742981C2 |
| TREATING PANCREATIC CANCER AND NON-SMALL CELL LUNG CANCER WITH ATR INHIBITORS | 2012 |
|
RU2648507C2 |
| COMPOSITION FOR APPLICATION IN PHOTODYNAMIC THERAPY OF CANCER | 2016 |
|
RU2626600C1 |
| METHOD OF INHIBITING TUMOUR GROWTH IN MAMMAL | 2018 |
|
RU2713153C1 |
| METHOD FOR OPTIMIZING LYMPH NODE DISSECTION IN PRIMARY RESECTABLE BREAST CANCER | 2017 |
|
RU2691568C1 |
| MEANS FOR TREATING MALIGNANT TUMORS BY APPLYING PHOTODYNAMIC THERAPY METHODS | 2006 |
|
RU2314806C1 |
| TETRA(PYREN-1-YL)TETRACYANOPORPHYRAZINE AS A MULTIFUNCTIONAL AGENT FOR THERAPY OF MALIGNANT GROWTHS | 2019 |
|
RU2725641C1 |
| PORPHYRAZINE, GADOLINIUS PORPHYRAZINE COMPLEX AND THEIR APPLICATION | 2016 |
|
RU2621710C1 |
